March 21, 2016
TUCSON, Ariz. -- HTG Molecular Diagnostics, Inc. (NASDAQ:HTGM), a provider of instruments and reagents for molecular profiling applications, today announced that it has entered into a long-term agreement with Thermo Fisher Scientific under which HTG will have the right to develop a number of in-vitro diagnostic (IVD) tests for use with Thermo Fisher’s next-generation sequencing [...]
SP Acquires PennTech Machinery Corporation
March 21, 2016
SP Industries, Inc. (SP), a leading designer and manufacturer of state-of-the-art laboratory equipment ; research, pilot and production freeze dryers ; laboratory supplies and glassware has announced that it has acquired the assets of privately held PennTech Machinery Corporation. Penntech is a global provider of complete vial handling solutions covering washing, sterilization, filling, stoppering, capping [...]
ORIGIN REMAINS COMMITTED TO ACQUISITION OF AFFYMETRIX
March 21, 2016
PALO ALTO, Calif.-- Origin Technologies Corporation, LLC (“Origin”), a newly created entity owned by a group of former Affymetrix executives for the purpose of privatizing Affymetrix, Inc. (“Affymetrix”, NASDAQ: AFFX), today issued the following statement: “We are committed to completing a friendly transaction with Affymetrix and reiterate our offer to acquire all of the company’s [...]
Thermo Fisher Scientific Issues Open Letter to Affymetrix Stockholders
March 20, 2016
WALTHAM, Mass.-- Thermo Fisher Scientific (NYSE:TMO), the world leader in serving science, today commented on the press release of Affymetrix, Inc. that responded to the unsolicited, non-binding proposal received on March 18, 2016, from Origin Technologies Corporation, LLC (the “Origin Proposal”). Thermo Fisher agrees with Affymetrix and its board of directors that the Origin Proposal [...]
Affymetrix Responds to Origin Proposal
March 20, 2016
SANTA CLARA, Calif. - Affymetrix Inc. (NASDAQ: AFFX) Affymetrix announced that it has reviewed the proposal made by Origin Technologies Corporation, LLC (“Origin”) on March 18 for a transaction in which the stockholders of Affymetrix would receive $16.10 per share in cash. In reviewing the proposal, the Board of Directors notes that Origin appears to [...]
Syrris launches application-focused Asia flow chemistry range
March 18, 2016
Syrris has updated its revolutionary Asia range of flow chemistry systems, introducing a number of new modules and application-focused solutions. Designed by chemists for chemists, these award-winning systems have been developed to offer exceptional ease of use and enable a wide variety of chemical reactions. The modular Asia range offers configurations to suit everything from [...]
Micronit and iX-factory have merged
March 18, 2016
Enschede, The Netherlands – Micronit Microfluidics B.V. (Micronit) and iX-factory GmbH announced today they have entered into a definitive merger agreement under which Micronit has acquired iX-factory. Both companies are experts in the development and manufacturing of innovative microfluidic and MEMS components. iX-factory will continue under the name of Micronit GmbH. “Both companies have unique [...]
Former Affymetrix Senior Executives Propose to Acquire Affymetrix for $16.10 Per Share in Cash
March 18, 2016
PALO ALTO, Calif. - Origin Technologies Corporation, LLC (“Origin”), a newly created entity owned by a group of former Affymetrix executives announced that it submitted a proposal to acquire Affymetrix, Inc. (“Affymetrix”) for $16.10 per share in an all-cash transaction valued at approximately $1.5 billion. This proposal represents a 75% premium to Affymetrix’ unaffected closing [...]
Introducing the Mad City Labs NSOM
March 18, 2016
The MCL-NSOM is a fully operational near field scanning optical microscope. It has been built on Mad City Labs versatile RM21™ inverted optical microscope which allows users to convert between NSOM, SPM, and fluorescence optical microscopy techniques. Complete inverted optical microscope Six axes of motorized control Closed loop nanopositioning in XYZ Independent automation for fiber [...]
March 18, 2016
OMAHA, Neb. — Transgenomic, Inc. (NASDAQ: TBIO) announced the launch of its EGFR C797S Mutation Detection Assay based on the company’s ICE COLD-PCR™ (ICP) technology. This new test detects the presence of the EGFR C797S mutation that is associated with resistance to new third-generation tyrosine kinase inhibitor (TKI) therapies in development for non-small cell lung [...]
